Bufomix Easyhaler budesonide/formoterol regulatory update

Orion said Ireland and Hungary approved its Bufomix Easyhaler budesonide/formoterol to treat asthma and chronic obstructive pulmonary disease (COPD) in patients ages >12 years. The approvals are the first under the EU's decentralized procedure; Sweden acted as the reference member state. Bufomix is also under review in Iceland, Norway and Switzerland. ...